Form 4: Macrogenics SVP, CFO and Secretary James Karrels Reports Changes in Beneficial Ownership
SEC Form 4 Filing
James Karrels, SVP, CFO, and Secretary of Macrogenics Inc., reports transactions involving common stock and restricted stock units.
Summary
- On February 15, 2025, James Karrels, the SVP, CFO, and Secretary of Macrogenics Inc., reported changes in beneficial ownership.
- Karrels acquired 14,998 shares of common stock upon the vesting of restricted stock units.
- Simultaneously, Karrels disposed of 5,790 shares of common stock to cover tax obligations at a price of $2.56 per share.
- Following these transactions, Karrels directly owns 186,801 shares of common stock and jointly owns 192,591 shares with his wife.
- Karrels also owns 14,999 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, reflecting standard transactions. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The remaining restricted stock units will vest in subsequent years, potentially leading to further transactions.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's securities, providing transparency to the market.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency of insider transactions.
- Similar filings are made by executives at companies like Amgen (AMGN), Biogen (BIIB), and Gilead Sciences (GILD) when they trade their company's stock.
- The reporting requirements and format are consistent across the industry, as mandated by the SEC.
Stakeholder Impact
- The transactions reported may have a minor impact on shareholders due to the change in insider ownership.
- The disposal of shares to cover tax obligations is a common practice and unlikely to significantly affect the company's financial position.
Key Dates
| Date | Description |
|---|---|
| 02/15/2023 | Reporting person was granted 45,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. |
| 02/15/2024 | 33% of the 45,000 restricted stock units granted on February 15, 2023 vested. |
| 02/15/2025 | Date of transaction: Acquisition of 14,998 shares via restricted stock unit vesting and disposal of 5,790 shares for tax obligations. |
| 02/19/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.